The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects. The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period. All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Acceptability of My Guide: Usefulness
Timeframe: T3 (immediately following 12 week intervention)
Acceptability of My Guide: Satisfaction
Timeframe: T3 (immediately following 12 week intervention)
Acceptability of My Guide: Learnability
Timeframe: T3 (immediately following 12 week intervention)
Acceptability of My Guide: Usability
Timeframe: T3 (immediately following 12 week intervention)
Demand of My Guide: Recruitment Rate
Timeframe: 12 weeks
Demand of My Guide: Retention Rate
Timeframe: 12 weeks
Participant use of My Guide: Number of Login's
Timeframe: 12 weeks
Participant use of My Guide: Duration of Usage
Timeframe: 12 weeks
Participant use of My Guide: Content Accessed
Timeframe: 12 weeks
Change in Medication adherence will be assessed primarily with the Adherence to Refills and Medication Scale (ARMS).
Timeframe: T1 (prior to starting intervention), T2 (6 weeks into intervention), T3 (immediately following 12 week intervention)